Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Thoracic Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Pulmonary And Respiratory Medicine

Anaplastic Lymphoma Kinase

Show all topics

DOI

10.1016/j.jtho.2019.03.007

License

CC-BY-NC-ND

Other Formats

PDF